Lv31
296 积分 2025-10-15 加入
Current state of CAR-T cell therapies for solid tumors
5小时前
已完结
Microenvironmental regulation of solid tumour resistance to CAR T cell therapy
4天前
已完结
Nanobody-based targeted cancer therapy and immunotherapy: fear not the future
4天前
已完结
Nanobody-based bispecific antibody engagers targeting CTLA-4 or PD-L1 for cancer immunotherapy
6天前
已完结
What nanobodies can do for you
6天前
已完结
Safety and pharmacokinetics of SOR102, an oral bispecific inhibitor of TNF and interleukin-23 in healthy participants and patients with ulcerative colitis: a first-in-human, double-blind, randomised, placebo-controlled, phase 1 trial
6天前
已完结
FDA approves first tumour-infiltrating lymphocyte (TIL) therapy, bolstering hopes for cell therapies in solid cancers
12天前
已完结
Preclinical development and a case report of a nanobody-based CLDN18.2 CAR-T IMC002 with reduced on-target off-tumor toxicity
14天前
已完结
Preclinical development and a case report of a nanobody-based CLDN18.2 CAR-T IMC002 with reduced on-target off-tumor toxicity
14天前
已完结
Tuning the sensitivity of mechanosensory receptors through histidine scanning
22天前
已完结
Keep calm and carry on—managing non‐TNF antagonist biologics in pregnancy
Genetic and clinical findings in a Chinese cohort with Leber congenital amaurosis and early onset severe retinal dystrophy
皖公网安备34019202002308
